These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 827983)

  • 1. [Microbiology of chronic lung diseases in children (author's transl)].
    Gargani GF; Ruffini G; Rossi C; Penna R; Romano C
    Ann Sclavo; 1976; 18(2):179-88. PubMed ID: 827983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative studies of bacterial flora in the bronchial and pharyngeal secretions and sputum in bronchopulmonary diseases].
    Pavlov R; Kalfin E
    Probl Tuberk; 1980 Dec; (12):48-50. PubMed ID: 6784116
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.
    Ratjen F; Döring G; Nikolaizik WH
    Lancet; 2001 Sep; 358(9286):983-4. PubMed ID: 11583754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Slime from a mucoid strain of Pseudomonas aeruginosa in mucoviscidosis and other respiratory diseases (author's transl)].
    Marty N; Lapchine L; Pradere J; Dutau G
    Ann Pediatr (Paris); 1981 Apr; 28(4):261-5. PubMed ID: 6784657
    [No Abstract]   [Full Text] [Related]  

  • 5. L forms in patients with cystic fibrosis.
    Bruns WT; Brown BA
    Am Rev Respir Dis; 1970 Jun; 101(6):935-40. PubMed ID: 4986861
    [No Abstract]   [Full Text] [Related]  

  • 6. Throat Swabs and Sputum Culture as Predictors of P. aeruginosa or S. aureus Lung Colonization in Adult Cystic Fibrosis Patients.
    Seidler D; Griffin M; Nymon A; Koeppen K; Ashare A
    PLoS One; 2016; 11(10):e0164232. PubMed ID: 27711152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of cefepime in the treatment of bronchopulmonary disease exacerbation in pediatric patients with mucoviscidosis].
    Semykin SIu; Postnikov SS; Polikarpova SV; Dubovik LG; Kolbatova ES
    Antibiot Khimioter; 2005; 50(4):18-22. PubMed ID: 16392335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus.
    Buchs C; Dalphin ML; Sanchez S; Perceval M; Coutier L; Mainguy C; Kassaï-Koupaï B; Reix P
    Eur J Pediatr; 2017 Jul; 176(7):891-897. PubMed ID: 28508992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frequency of isolation and drug resistance of bacterial strains isolated from respiratory material in patients with cystic fibrosis].
    Rosselli P
    Quad Sclavo Diagn; 1986 Sep; 22(3):273-82. PubMed ID: 3112860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of Staphylococcus aureus from sputum in cystic fibrosis.
    Sparham PD; Lobban DI; Speller DC
    J Clin Pathol; 1978 Oct; 31(10):913-8. PubMed ID: 101553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis.
    Baltimore RS; Radnay-Baltimore K; von Graevenitz A; Dolan TF
    Helv Paediatr Acta; 1982; 37(6):547-54. PubMed ID: 6820015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.
    Blau H; Linnane B; Carzino R; Tannenbaum EL; Skoric B; Robinson PJ; Robertson C; Ranganathan SC
    J Cyst Fibros; 2014 Jan; 13(1):106-10. PubMed ID: 23806622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis.
    Mainz JG; Naehrlich L; Schien M; Käding M; Schiller I; Mayr S; Schneider G; Wiedemann B; Wiehlmann L; Cramer N; Pfister W; Kahl BC; Beck JF; Tümmler B
    Thorax; 2009 Jun; 64(6):535-40. PubMed ID: 19282318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center.
    Lee TW; Brownlee KG; Denton M; Littlewood JM; Conway SP
    Pediatr Pulmonol; 2004 Feb; 37(2):104-10. PubMed ID: 14730654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.
    Ciofu O; Riis B; Pressler T; Poulsen HE; Høiby N
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2276-82. PubMed ID: 15917521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of sputum cultures in children under 2 years of age with chronic suppurative lung diseases.
    Stafler P; Zaks-Hoffer G; Scheuerman O; Ben-Zvi H; Mussaffi H; Mei-Zahav M; Steuer G; Levine H; Bar-On O; Mantin H; Prais D; Blau H
    Pediatr Pulmonol; 2020 Dec; 55(12):3421-3428. PubMed ID: 33006230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Escherichia coli, coliform bacteria, Pseudomonas aeruginosa, Proteus and Staphylococcus aureus carriers among children 5-15 years old].
    Yumul C; Aras S; Sönmez H; Sevük N
    Mikrobiyol Bul; 1986 Jul; 20(3):176-83. PubMed ID: 3104734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriological studies of bronchial secretions in 19 cases of cystic fibrosis.
    Feigelson J; Pecau Y
    Bibl Paediatr; 1967; 86():214-26. PubMed ID: 4964164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.